Patents by Inventor Jean-Francois Nave

Jean-Francois Nave has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
    Patent number: 8846654
    Abstract: A subject-matter of the present invention is the use of compounds of formula (I) in the base, hydrate or solvate form or in the form of their mixtures, as medicaments or for the preparation of medicaments intended for the treatment of at least one cardiovascular disease and/or to prevent the appearance of at least one cardiovascular disease.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: September 30, 2014
    Assignee: Sanofi
    Inventors: Philip Janiak, Gilbert Marciniak, Jean-Francois Nave, Fabrice Viviani
  • Therapeutic uses of quinazolinedione derivatives
    Patent number: 8748441
    Abstract: The subject matter of the present invention is the use of compounds of formula (I) in the form of a base, a hydrate or a solvate, or of mixtures thereof, as a medicament or for preparing a medicament intended for the treatment and/or prevention of disorders associated with the central nervous system (abbreviated to CNS) and/or associated with the peripheral nervous system (abbreviated to PNS).
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: June 10, 2014
    Assignee: SANOFI
    Inventors: Gilbert Marciniak, Jean-Francois Nave, Fabrice Viviani
  • Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
    Patent number: 8722659
    Abstract: The subject matter of the invention is quinazolinedione derivatives of formula (I), methods for obtaining same and therapeutic uses thereof, such as cancer, diabetes, muscle diseases, bone diseases, cardiovascular diseases, central nervous system diseases, peripheral nervous system diseases, inter alia.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: May 13, 2014
    Assignee: Sanofi
    Inventors: Annie Clauss, Christophe Glaess, Gilbert Marciniak, Jean-Francois Nave, Bertrand Vivet
  • Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
    Patent number: 8242126
    Abstract: The invention relates to quinazolinedione derivatives of the general formula (I): wherein A, R1, R2, R3, R4, m, n, p, p?, and r are as defined herein, processes for the preparation thereof and their therapeutic applications.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: August 14, 2012
    Assignee: Sanofi
    Inventors: Annie Clauss, Christophe Glaess, Gilbert Marciniak, Nicolas Muzet, Jean-Francois Nave, André Seyer, Bertrand Vivet
  • THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES
    Publication number: 20120184522
    Abstract: A subject-matter of the present invention is the use of compounds of formula (I) in the base, hydrate or solvate form or in the form of their mixtures, as medicaments or for the preparation of medicaments intended for the treatment of at least one cardiovascular disease and/or to prevent the appearance of at least one cardiovascular disease.
    Type: Application
    Filed: October 7, 2011
    Publication date: July 19, 2012
    Applicant: SANOFI
    Inventors: Philip JANIAK, Gilbert MARCINIAK, Jean-Francois NAVE, Fabrice VIVIANI
  • QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND VARIOUS THERAPEUTIC USES THEREOF.
    Publication number: 20120115846
    Abstract: The subject matter of the invention is quinazolinedione derivatives of formula (I), methods for obtaining same and therapeutic uses thereof, such as cancer, diabetes, muscle diseases, bone diseases, cardiovascular diseases, central nervous system diseases, peripheral nervous system diseases, inter alia.
    Type: Application
    Filed: October 7, 2011
    Publication date: May 10, 2012
    Applicant: SANOFI
    Inventors: Annie CLAUSS, Christophe GLAESS, Gilbert MARCINIAK, Jean-Francois NAVE, Bertrand VIVET
  • THERAPEUTIC USES OF QUINAZOLINEDIONE DERIVATIVES
    Publication number: 20120058987
    Abstract: The subject matter of the present invention is the use of compounds of formula (I) in the form of a base, a hydrate or a solvate, or of mixtures thereof, as a medicament or for preparing a medicament intended for the treatment and/or prevention of disorders associated with the central nervous system (abbreviated to CNS) and/or associated with the peripheral nervous system (abbreviated to PNS).
    Type: Application
    Filed: March 25, 2010
    Publication date: March 8, 2012
    Applicant: SANOFI
    Inventors: Gilbert Marciniak, Jean-Francois Nave, Fabrice Viviani
  • QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF
    Publication number: 20100298298
    Abstract: The invention relates to quinazolinedione derivatives, processes for the preparation thereof and their therapeutic applications.
    Type: Application
    Filed: April 5, 2010
    Publication date: November 25, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Annie CLAUSS, Christophe GLAESS, Gilbert MARCINIAK, Nicolas MUZET, Jean-Francois NAVE, André SEYER, Bertrand VIVET
  • Unsaturated phosphonate derivatives of purines and pyrimidines
    Publication number: 20040068111
    Abstract: Disclosed are novel unsaturated phosphonate derivatives of certain purines or pyrimidines useful as antiviral agents, methods useful for their preparation and use of these compounds as antiviral agents effective against DNA viruses, retroviruses and viruses involved in tumor formation.
    Type: Application
    Filed: September 16, 2003
    Publication date: April 8, 2004
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: Patrick Casara, Jean-Francois Nave, Serge Halazy
  • Unsaturated phosphonate derivatives of purines and pyrimidines
    Publication number: 20030004345
    Abstract: Disclosed are novel unsaturated phosphonate derivatives of certain purines or pyrimidines useful as antiviral agents, methods useful for their preparation and use of these compounds as antiviral agents effective against DNA viruses, retroviruses and viruses involved in tumor formation.
    Type: Application
    Filed: June 4, 2002
    Publication date: January 2, 2003
    Inventors: Patrick Casara, Jean-Francois Nave, Serge Halazy
  • Fluorinated arachidonic acid derivatives
    Patent number: 5225429
    Abstract: Fluorinated arachidonic derivatives are 5-lipoxygenase inhibitors which have the useful pharmacologic activity as antiallergy and anti-inflammatory agents and are useful for treating, for example, asthma, anaphylaxis, allergy, rheumatoid arthritis, and psoriasis and cardiovascular diseases.
    Type: Grant
    Filed: June 24, 1991
    Date of Patent: July 6, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Jean-Bernard Ducep, Jean-Francois Nave, Detlef Jacobi
  • Fluorinated arachidonic acid derivatives
    Patent number: 5145861
    Abstract: Fluorinated arachidonic derivatives are 5-lipoxygenase inhibitors which have the useful pharmacologic activity as antiallergy and anti-imflammatory agents and are useful for treating, for example, asthma, anaphylaxis, allergy, rheumatoid arthritis, and psoriasis.
    Type: Grant
    Filed: August 5, 1991
    Date of Patent: September 8, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Jean B. Ducep, Jean-Francois Nave